Endothelin-1 Receptor antibody (Extracellular)
Quick Overview for Endothelin-1 Receptor antibody (Extracellular) (ABIN7581867)
Target
See all Endothelin-1 Receptor (EDNRA) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 329-341, Extracellular
-
Purpose
- A Rabbit Ployclonal Antibody to Endothelin Receptor A
-
Sequence
- KKTVYDEMDK NRC
-
Specificity
- Extracellular, 3rd loop.
-
Predicted Reactivity
- Mouse - identical Human - 12 out of 13 amino acid residues identical
-
Characteristics
- Anti-Endothelin Receptor A (extracellular) Antibody (ABIN7581867) is a highly specific antibody directed against an extracellular epitope of the rat protein. The antibody can be used in western blot and indirect flow cytometry applications. It has been designed to recognize ET-A Receptor from mouse, rat and human samples.
-
Purification
- Affinity purified on immobilized antigen.
-
Immunogen
- KKTVYDEMDKNRC, corresponding to amino acid residues 329 - 341 of rat EDNRA
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Antigen preadsorption control: 1 μg peptide per 1 μg antibody
Application Dilutions Immunohistochemistry paraffin embedded sections ihc: N/A
Application Dilutions Western blot wb: 1:200-1:400
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- 0.2 mL double distilled water (DDW).
-
Concentration
- 1 mg/mL
-
Buffer
- PBS pH 7.4
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.
Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).
-
-
- Endothelin-1 Receptor (EDNRA) (Endothelin Receptor Type A (EDNRA))
-
Alternative Name
- EDNRA
-
Background
- EDNRA, ET-A, ET-AR, ETRA, ET1-Specific type endothelin receptor, Endothelin-1 receptor, Endothelin Receptor Type A,The endothelin system is comprised of three active peptides, ET-1, 2, and 3, which are considered to be very powerful vasoconstrictive substances. In humans, endothelins mediate their actions via two specific G-Protein Coupled Receptors, ETAR and ETBR. Both ETAR and ETBR are present in heart and in human myocardium at similar levels.1,2The endothelin receptors differ in their ligand specificity. While ETAR has varying affinities for the endothelin isoforms (ET-1 >ET-2>ET-3), ETBR shows no selective affinity.2,3 Subsequent studies have demonstrated the presence of endothelins in vascular as well as in non-vascular cells and tissues, having multiple biological activities.Currently, there is increasing evidence that ET-1 may modulate mitogenesis, apoptosis, angiogenesis tumor invasion and the development of metastases.3Overexpression of ET-1 and ETAR was reported in different malignancies including prostate cancer human Kaposi's sarcoma, ovarian and breast carcinomas.4In breast carcinomas overexpression of ET-1 and ETA receptors correlated with parameters that characterize aggressive types of breast cancer suggesting that analysis of ETAR expression might be used as a diagnostic marker for evaluating the progression of the disease and effectiveness of treatment. These and other findings have made ET receptors, and especially ETAR, promising therapeutic targets for pharmacological intervention.5-9
-
Gene ID
- 24326
-
UniProt
- P26684
-
Pathways
- cAMP Metabolic Process
Target
-